Progenics Pharmaceuticals, Inc.
Tarveda Therapeutics
Hutchinson Medipharma Limited
Advanced Accelerator Applications
Exelixis, Inc.
Dauntless Pharmaceuticals, Inc.
Novartis AG
Ispen
1 Neuroendocrine Tumor Treatment Market Overview
1.1 Product Overview and Scope of Neuroendocrine Tumor Treatment
1.2 Classification of Neuroendocrine Tumor Treatment by Types
1.2.1 Global Neuroendocrine Tumor Treatment Revenue Comparison by Types (2020-2025)
1.2.2 Global Neuroendocrine Tumor Treatment Revenue Market Share by Types in 2018
1.2.3 Everolimus
1.2.4 Sunitinib
1.2.5 Lu-Dotatate
1.2.6 Lanreotide
1.2.7 Octreotide
1.3 Global Neuroendocrine Tumor Treatment Market by Application
1.3.1 Global Neuroendocrine Tumor Treatment Market Size and Market Share Comparison by Applications (2015-2025)
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Global Neuroendocrine Tumor Treatment Market by Regions
1.4.1 Global Neuroendocrine Tumor Treatment Market Size (Million USD) Comparison by Regions (2015-2025)
1.4.1 North America (USA, Canada and Mexico) Neuroendocrine Tumor Treatment Status and Prospect (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Neuroendocrine Tumor Treatment Status and Prospect (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neuroendocrine Tumor Treatment Status and Prospect (2015-2025)
1.4.4 South America (Brazil, Argentina, Colombia) Neuroendocrine Tumor Treatment Status and Prospect (2015-2025)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neuroendocrine Tumor Treatment Status and Prospect (2015-2025)
1.5 Global Market Size of Neuroendocrine Tumor Treatment (2015-2025)
2 Company Profiles
2.1 Progenics Pharmaceuticals, Inc.
2.1.1 Business Overview
2.1.2 Neuroendocrine Tumor Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2019)
2.2 Tarveda Therapeutics
2.2.1 Business Overview
2.2.2 Neuroendocrine Tumor Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Tarveda Therapeutics Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2019)
2.3 Hutchinson Medipharma Limited
2.3.1 Business Overview
2.3.2 Neuroendocrine Tumor Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2019)
2.4 Advanced Accelerator Applications
2.4.1 Business Overview
2.4.2 Neuroendocrine Tumor Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Advanced Accelerator Applications Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2019)
2.5 Exelixis, Inc.
2.5.1 Business Overview
2.5.2 Neuroendocrine Tumor Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Exelixis, Inc. Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2019)
2.6 Dauntless Pharmaceuticals, Inc.
2.6.1 Business Overview
2.6.2 Neuroendocrine Tumor Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2019)
2.7 Novartis AG
2.7.1 Business Overview
2.7.2 Neuroendocrine Tumor Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis AG Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2019)
2.8 Ispen
2.8.1 Business Overview
2.8.2 Neuroendocrine Tumor Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Ispen Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2019)
3 Global Neuroendocrine Tumor Treatment Market Competition, by Players
3.1 Global Neuroendocrine Tumor Treatment Revenue and Share by Players (2015-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Neuroendocrine Tumor Treatment Players Market Share
3.2.2 Top 10 Neuroendocrine Tumor Treatment Players Market Share
3.3 Market Competition Trend
4 Global Neuroendocrine Tumor Treatment Market Size by Regions
4.1 Global Neuroendocrine Tumor Treatment Revenue and Market Share by Regions
4.2 North America Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
4.3 Europe Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
4.4 Asia-Pacific Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
4.5 South America Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
4.6 Middle East and Africa Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
5 North America Neuroendocrine Tumor Treatment Revenue by Countries
5.1 North America Neuroendocrine Tumor Treatment Revenue by Countries (2015-2019)
5.2 USA Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
5.3 Canada Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
5.4 Mexico Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
6 Europe Neuroendocrine Tumor Treatment Revenue by Countries
6.1 Europe Neuroendocrine Tumor Treatment Revenue by Countries (2015-2019)
6.2 Germany Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
6.3 UK Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
6.4 France Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
6.5 Russia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
6.6 Italy Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
7 Asia-Pacific Neuroendocrine Tumor Treatment Revenue by Countries
7.1 Asia-Pacific Neuroendocrine Tumor Treatment Revenue by Countries (2015-2019)
7.2 China Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
7.3 Japan Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
7.4 Korea Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
7.5 India Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
7.6 Southeast Asia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
8 South America Neuroendocrine Tumor Treatment Revenue by Countries
8.1 South America Neuroendocrine Tumor Treatment Revenue by Countries (2015-2019)
8.2 Brazil Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
8.3 Argentina Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
8.4 Colombia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
9 Middle East and Africa Revenue Neuroendocrine Tumor Treatment by Countries
9.1 Middle East and Africa Neuroendocrine Tumor Treatment Revenue by Countries (2015-2019)
9.2 Saudi Arabia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
9.3 UAE Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
9.4 Egypt Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
9.5 Nigeria Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
9.6 South Africa Neuroendocrine Tumor Treatment Revenue and Growth Rate (2015-2019)
10 Global Neuroendocrine Tumor Treatment Market Segment by Type
10.1 Global Neuroendocrine Tumor Treatment Revenue and Market Share by Type (2015-2019)
10.2 Global Neuroendocrine Tumor Treatment Market Forecast by Type (2020-2025)
10.3 Everolimus Revenue Growth Rate (2015-2025)
10.4 Sunitinib Revenue Growth Rate (2015-2025)
10.5 Lu-Dotatate Revenue Growth Rate (2015-2025)
10.6 Lanreotide Revenue Growth Rate (2015-2025)
10.7 Octreotide Revenue Growth Rate (2015-2025)
11 Global Neuroendocrine Tumor Treatment Market Segment by Application
11.1 Global Neuroendocrine Tumor Treatment Revenue Market Share by Application (2015-2019)
11.2 Neuroendocrine Tumor Treatment Market Forecast by Application (2020-2025)
11.3 Hospitals Revenue Growth (2015-2019)
11.4 Clinic Revenue Growth (2015-2019)
11.5 Others Revenue Growth (2015-2019)
12 Global Neuroendocrine Tumor Treatment Market Size Forecast (2020-2025)
12.1 Global Neuroendocrine Tumor Treatment Market Size Forecast (2020-2025)
12.2 Global Neuroendocrine Tumor Treatment Market Forecast by Regions (2020-2025)
12.3 North America Neuroendocrine Tumor Treatment Revenue Market Forecast (2020-2025)
12.4 Europe Neuroendocrine Tumor Treatment Revenue Market Forecast (2020-2025)
12.5 Asia-Pacific Neuroendocrine Tumor Treatment Revenue Market Forecast (2020-2025)
12.6 South America Neuroendocrine Tumor Treatment Revenue Market Forecast (2020-2025)
12.7 Middle East and Africa Neuroendocrine Tumor Treatment Revenue Market Forecast (2020-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
